Zephyrnet Logo

Tag: Sight Diagnostics

Newsletter: Connecting Israel and the UAE + Digital Health + Growth for Farmers

Showcasing the Startup Nation to our new partnersin the United Arab Emirates OurCrowd will create history on Sep. 22 when we host the first...

Newsletter: Safer Scooters in Rome + SEC’s Historic Decision + El Al in Abu Dhabi

Safer Scooters on the Streets of Rome, Heading to London Trials LINK, the shared electric scooter service created by OurCrowd portfolio company Superpedestrian, launches...

Newsletter: Food Tech Heats Up

Quality and Taste Triple Tovala Sales Ahead of Investment Round Smart meal service delivery company outperforms competition OurCrowd investors join Series B round led by...

[PRESS RELEASE] SIGHT DIAGNOSTICS RAISES $71M TO ACCELERATE GLOBAL EXPANSION OF ITSFDA 510(K) CLEARED, CE MARKED FINGER-PRICK BLOOD ANALYZER

Tel Aviv, Israel (August 5, 2020) – Sight Diagnostics, the company behind the first FDA-cleared direct-from-fingerstick Complete Blood Count (CBC) analyzer, announced today...

Tabletop blood tester Sight Diagnostics raises $71M to expand commercial reach

Sight Diagnostics has raised $71 million to help expand the commercial reach of its FDA-cleared, tabletop machine for analyzing a finger-prick’s worth of...

[Sight Diagnostics in Crowdfund Insider] Koch Disruptive Technologies Invests in Sight Diagnostics Alongside OurCrowd in $71 Million Series D

Koch Disruptive Technologies has announced an investment in Sight Diagnostics alongside global crowdfunding platform OurCrowd. Sight Diagnostics is a long time portfolio company of OurCrowd. The Series D...

[Sight Diagnostics in The New York Times] Israel’s Sight Diagnostics Raises $71 Million for Its Blood Analyzer

Israel’s Sight Diagnostics said on Wednesday it raised $71 million in private funding to expand sales of its finger-prick blood analyzer and support...

[Sight Diagnostics in Tech Crunch] Sight Diagnostics raises $71M Series D for its blood analyzer

Sight Diagnostics, the Israel-based health-tech company behind the FDA-cleared OLO blood analyzer, today announced that it has raised a $71 million Series D...

Sight Diagnostics raises another $71M to fully commercialize its blood analyzer

Tel Aviv, Israel-based Sight Diagnostics, which makes a complete blood count (CBC) analyzer only requiring two drops of blood, announced Wednesday that it...

OurCrowd launches $100M Pandemic Innovation Fund

OurCrowd, the Israeli crowdfunding venture investment platform, today announced the launch of its Pandemic Innovation Fund, with plans to raise a total of...

In the News: Coronavirus, industry reinvention & venture capital

The coronavirus crisis has created heightened awareness of healthcare challenges, which will cause more money to flow to what we have seen as...

Latest Intelligence

spot_img
spot_img